Angiotensinogen RNAi therapeutic lowers blood pressure in combination with standard antihypertensive
Beneficial effects of GLP-1RA in patients with obesity-related HFpEF and T2D
Mikhail Kosiborod, MD
Effects of aldose reductase inhibitor on exercise capacity in diabetic cardiomyopathy
James Januzzi, MD
Targeting cardiac energetics with cardiac mitotrope in nonobstructive HCM
Martin Maron, MD
Long-term improvements in daily steps with gamification and financial incentives in patients at risk for CV events
Alexander Fanaroff, MD
Loading...
We’re glad to see you’re enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.